Fred Alger Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-106,841
| Closed | -$982K | – | 526 |
|
|
2023
Q1 | $982K | Buy |
106,841
+18
| +0% | +$165 | 0.01% | 387 |
|
|
2022
Q4 | $1.09M | Buy |
106,823
+432
| +0.4% | +$4.41K | 0.01% | 375 |
|
|
2022
Q3 | $1.57M | Hold |
106,391
| – | – | 0.01% | 354 |
|
|
2022
Q2 | $1.14M | Sell |
106,391
-2,123
| -2% | -$22.8K | 0.01% | 367 |
|
|
2022
Q1 | $1.17M | Sell |
108,514
-574
| -0.5% | -$6.19K | ﹤0.01% | 377 |
|
|
2021
Q4 | $1.78M | Sell |
109,088
-3,892
| -3% | -$63.5K | ﹤0.01% | 366 |
|
|
2021
Q3 | $2.42M | Buy |
+112,980
| New | +$2.42M | 0.01% | 340 |
|